Prestige Consumer Healthcare Inc. ( PBH ) Nowojorska Giełda Papierów Wartościowych

Cena: 66.71 ( 1.93% )

Aktualizacja 08-22 21:59
Nowojorska Giełda Papierów Wartościowych
Branża: Medical - Distribution

Notowania:

Opis firmy:

Prestige Consumer Healthcare Inc., wraz z spółkami zależnymi, rozwija, produkuje, rynki, dystrybuuje i sprzedaje produkty zdrowotne i higieny osobistej OTC (OTC) w Stanach Zjednoczonych i na arenie międzynarodowej. Firma działa w dwóch segmentach, North American OTC Healthcare i International OTC Healthcare. Oferuje proszki przeciwbólowe BC/Goody'ego, maści Budreauxa maści dla dzieci, chloraseptyczne ciecze i ssaki, czyste oczy do ulgi zaczerwienienia oczu, usuwania brodawki, wciągnięcia do pielęgnacji ustnej, usuwania wosku z ucha grubego i dramaminę. Firma zapewnia również floty dorosłe lewatywy/czopki, środki żołądkowe Gaviscona, krople kaszel Ludena, monistat pochwy przeciwgrzybiczy, leczenie wszy Nix/pasożyt, letnia higiena żeńska, sucha ulga oczu, solą solidną, spray na soli nosa. Sprzedaje swoje produkty za pośrednictwem masowych kupców; oraz narkotyki, jedzenie, dolar, wygoda i sklepy klubowe, a także kanały e-commerce. Firma była wcześniej znana jako Prestige Brands Holdings, Inc. i zmieniła nazwę na Prestige Consumer Healthcare Inc. w sierpniu 2018 r. Prestige Consumer Healthcare Inc. został założony w 1996 roku i ma siedzibę w Tarrytown w Nowym Jorku.

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Distribution
Zatrudnienie: 570
Giełda: Nowojorska Giełda Papierów Wartościowych
Ilość akcji w obrocie: 99.33399942848634
Ilość akcji: Brak danych
Debiut giełdowy: 2005-02-10
WWW: https://www.prestigebrands.com
CEO: Mr. Ronald M. Lombardi CPA
Adres: 660 White Plains Road
Siedziba: 10591 Tarrytown
ISIN: US74112D1019
Wskaźniki finansowe
Kapitalizacja (USD) 3 283 079 282
Aktywa: 3 316 885 000
Cena: 66.71
Wskaźnik Altman Z-Score: 2.9
Umiarkowany (ryzyko bankructwa średnie)
Dywidenda: 0
P/E: 15.7
Ilość akcji w obrocie: 99%
Średni wolumen: 439 612
Ilość akcji 49 214 200
Wskaźniki finansowe
Przychody TTM 1 110 422 000
Zobowiązania: 1 585 124 000
Przedział 52 tyg.: 62.95 - 90.04
Piotroski F-Score: 8
Silny (dobra jakość finansowa)
EPS: 4.3
P/E branży: 17.8
Beta: 0.471
Raport okresowy: 2025-11-06
WWW: https://www.prestigebrands.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Ms. Christine Sacco Chief Financial Officer 970 884 1976
Mr. William C. P'Pool Senior Vice President, General Counsel & Corporate Secretary 803 871 1965
Mr. Adel Mekhail Executive Vice President of Marketing & Sales 803 521 1961
Mr. Jeffrey Zerillo Senior Vice President of Operations 502 918 1961
Mr. Ronald M. Lombardi Chairman, President & Chief Executive Officer 2 063 099 1964
Dean Siegal Director of Communications 0 0
Ms. Mary Beth Fritz Senior Vice President of Quality & Regulatory Affairs 0 0
Mr. Philip David Terpolilli Director of Investor Relations 0 0
Lista ETF z ekspozycją na akcje Prestige Consumer Healthcare Inc.
Symbol ETF Ilość akcji Wartość
IJR 2 997 244 221 646 196
VB 1 207 744 96 438 358
IWM 1 205 599 89 154 066
SCYB 1 036 000 1 001 421
VBR 770 422 61 518 196
JPIE 690 000 684 247
SPSM 428 800 32 295 586
BBHY 418 000 382 514
XHY.TO 415 000 542 445
IWN 358 382 26 502 332
IJT 263 690 19 499 841
VTWO 251 516 20 083 552
SCHA 233 327 17 347 788
DFAT 205 009 15 160 415
IJS 189 045 13 979 889
VIOO 163 585 13 062 262
VHT 154 228 12 315 105
SLYG 145 028 10 897 740
DFAS 143 572 10 617 149
IHE 135 626 10 029 554
DFAC 118 191 8 740 224
GHYB 116 000 107 740
FNDA 114 146 8 469 716
SLYV 110 644 8 420 423
DFSV 109 549 8 101 148
VCN.TO 108 164 8 785 080
CSMD 103 535 7 656 413
VDY.TO 92 233 7 491 164
IWO 79 626 5 888 313
R2SC.L 75 167 4 279 464
R2US.L 75 167 5 647 296
ZPRR.DE 75 167 4 945 337
IUS3.DE 73 076 4 727 376
IDP6.L 73 076 5 403 950
ISP6.L 73 076 4 090 142
PJP 72 328 5 434 002
XPH 65 687 4 966 000
ITOT 64 321 4 756 555
BBHY 63 000 62 474
FESM 54 532 4 160 791
JSCP 54 000 53 549
PRFZ 52 080 3 912 770
USVM 50 928 3 766 125
PSCH 47 377 3 559 434
VIOV 39 995 3 193 600
DFUV 36 287 2 683 423
VIOG 35 311 2 819 583
SMMV 31 932 2 399 051
FSMD 30 306 2 312 347
SCHB 29 463 2 205 218
XRSG.L 29 279 164 074 528
XRSU.L 29 279 2 165 171
XRS2.DE 29 279 1 896 040
DWAS 27 921 2 097 704
DHYG.L 27 788 1 555 351
VTWV 26 639 2 127 124
DHYC.SW 25 882 1 555 351
VFMO 25 634 2 046 874
XSLV 25 236 1 895 980
RSSL 25 222 1 865 166
UEEF.DE 24 043 1 555 351
BBMC 22 026 1 628 822
SMLF 21 652 1 601 170
DHYE.AS 21 032 1 360 621
DHYD.AS 21 032 1 555 351
DHYA.L 21 032 1 555 351
FHLC 20 897 1 594 441
XB 20 000 0
DHYG.L 19 774 1 106 779
TMSL 19 702 1 456 962
PSC 19 291 1 426 569
DHYC.SW 18 417 1 106 779
BINC 17 839 1 319 202
IJR.AX 17 445 2 028 456
UEEF.DE 17 109 1 106 779
JPSE 16 431 1 215 072
GSSC 15 533 1 224 932
BSMC 15 467 1 143 784
DHYA.L 14 967 1 106 779
DHYD.AS 14 967 1 106 779
DHYE.AS 14 967 968 211
RWJ 14 422 1 083 524
HYSD.L 14 356 803 547
IWV 13 740 1 016 058
FYX 12 850 981 868
SIXS 12 540 0
AVUS 11 503 864 220
HYSD.L 11 255 629 946
HYUS.L 10 866 803 547
HYUS.SW 10 866 803 547
ESGV 10 709 855 113
SIXL 10 267 0
BINC 10 083 745 640
JHSC 9 906 872 124
SPTM 9 533 717 419
DFAU 9 181 678 934
EZM 9 125 674 793
XSU.TO 8 534 885 517
SMLV 8 522 647 337
HYUS.L 8 519 629 946
HYUS.SW 8 519 629 946
QVMS 8 100 608 553
VTWG 8 036 641 674
VFMV 7 234 577 634
JMEE 7 214 533 475
SAEF 6 880 567 259
ISCG 5 839 431 772
PDN 5 830 372 709
IHHG.L 5 513 308 551
OMFS 5 416 406 904
ISMD 5 025 371 598
UWM 5 009 370 415
SXRG.DE 4 972 321 651
CUSS.L 4 972 367 686
CUS1.L 4 972 278 294
CSUSS.MI 4 972 321 651
IBC2.DE 4 770 308 551
IHYE.L 4 770 308 551
ZPRV.DE 4 273 244 883
USSC.L 4 273 279 643
GHYG.L 4 225 236 485
IHYU.L 4 172 308 551
IS0R.DE 4 172 269 920
IHYU.MI 4 172 269 920
SHYU.L 4 172 233 536
IHYA.L 4 172 308 551
URTY 4 145 306 522
DFSU 4 143 306 374
AFMC 4 135 315 955
FLQS 4 008 301 121
HYLC.SW 3 935 236 485
XJR 3 905 293 382
VTHR 3 866 308 700
DCOR 3 791 280 344
HYLE.DE 3 656 236 485
HYLA.L 3 198 236 485
IBC9.DE 3 198 206 877
HYLD.L 3 198 236 485
IGHY.L 3 198 178 991
JPSV 2 816 224 857
TILT 2 718 200 996
CAFG 2 638 195 080
PILL 2 405 177 849
ISCB 2 204 162 956
XUU.TO 2 114 219 319
FYT 1 945 148 617
TLTD 1 824 115 887
XSMC.TO 1 741 180 640
SQLV 1 629 122 386
XSMH.TO 1 610 167 091
HSMV 1 534 117 212
STXK 1 529 113 069
FTXH 1 402 107 126
SDHA.L 1 342 99 212
SDHY.L 1 342 99 212
SDHG.L 1 342 75 092
IS3K.DE 1 342 86 791
MFDX 1 086 69 297
ROSC 1 063 79 863
FNDB 911 63 213
SAA 911 67 368
DXUV 661 48 880
CSA 651 52 229
V3AL.L 603 48 149
V3AB.L 603 36 487
V3AA.L 603 48 149
VLU 526 39 743
V3AA.L 514 30 595
V3AB.L 514 23 184
V3AL.L 514 30 595
GHYS.L 436 24 422
ESIX 384 29 014
FAB 372 28 424
XBAL.TO 365 37 906
XUH.TO 312 23 443
CBUG.DE 242 15 642
EWSA.AS 242 17 880
EBIT 231 17 355
USFM.L 226 16 961
USUE.DE 226 16 961
MFUS 218 16 378
CSF 203 16 286
IHHY.AX 192 27 162
GVLU 149 0
XTR.TO 141 18 254
GHYC.SW 134 8 044
GHYS.L 133 7 464
GHYC.SW 125 7 519
MMTM 86 6 447
IHHG.L 66 3 709
HDG 60 4 437
IHYE.L 57 3 709
IBC2.DE 57 3 709
SHYU.L 50 2 807
IHYA.L 50 3 709
IS0R.DE 50 3 245
IHYU.MI 50 3 245
IHYU.L 50 3 709
AVIE 36 2 704
XTR.TO 13 948
SC0K.DE 0 304 385
PSWD.DE 0 40 623
USML.L 0 527 026
PZW.TO 0 18 321
PLV.TO 0 3 119
RTYS.L 0 347 393
PSRW.L 0 3 521 696
Wiadomości dla Prestige Consumer Healthcare Inc.
Tytuł Treść Źródło Aktualizacja Link
PBH vs. ESLOY: Which Stock Should Value Investors Buy Now? Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks presents investors with the better value opportunity right now? zacks.com 2025-05-14 16:45:44 Czytaj oryginał (ang.)
Prestige Consumer Healthcare Inc. (PBH) Q4 2025 Earnings Call Transcript Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q4 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Phil Terpolilli – Vice President, Investor Relations and Treasury Ron Lombardi – Chairman, President and Chief Executive Officer Christine Sacco – Chief Financial Officer and Chief Operating Officer Conference Call Participants Rupesh Parikh – Oppenheimer Susan Anderson – Canaccord Keith Devas – Jefferies Glenn West – William Blair Anthony Lebiedzinski – Sidoti & Company Doug Lane – Water Tower Research Operator Good day, and thank you for standing by. Welcome to the Prestige Consumer Healthcare's Fourth Quarter 2025 Earnings Conference Call. seekingalpha.com 2025-05-11 10:53:50 Czytaj oryginał (ang.)
Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.30 per share. This compares to earnings of $1.02 per share a year ago. zacks.com 2025-05-08 12:20:37 Czytaj oryginał (ang.)
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) --  Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025. globenewswire.com 2025-05-08 11:09:00 Czytaj oryginał (ang.)
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) --  Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025. globenewswire.com 2025-05-08 10:00:00 Czytaj oryginał (ang.)
PBH or ABT: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com 2025-04-28 16:45:25 Czytaj oryginał (ang.)
Premium Brands Holdings Corporation to Release First Quarter 2025 Results Vancouver, British Columbia--(Newsfile Corp. - April 24, 2025) - Premium Brands Holdings Corporation (TSX: PBH) (the "Company"), a leading producer, marketer and distributor of branded specialty food products, will release its first quarter 2025 results on Wednesday, May 7, 2025. Pre-recorded Management Remarks, Press Release and Investor Presentation Please note that management's pre-recorded remarks, a press release including financial statements and segment information and an investor presentation will be available on the morning of Wednesday, May 7, 2025 at 4:00 a.m. newsfilecorp.com 2025-04-24 14:00:00 Czytaj oryginał (ang.)
3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes Here, we discuss three medical device stocks ,COR, HIMS and PBH, that offer cheap valuations, making them attractive bets amid tariff risks. zacks.com 2025-04-17 14:55:44 Czytaj oryginał (ang.)
Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results TARRYTOWN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 fourth quarter and year-end earnings release on Thursday, May 8, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. globenewswire.com 2025-04-10 21:00:00 Czytaj oryginał (ang.)
PBH vs. SYK: Which Stock Is the Better Value Option? Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now? zacks.com 2025-04-10 16:40:38 Czytaj oryginał (ang.)
Prestige Consumer Gains 17.1% in a Year: What's Driving the Stock? PBH's shares rise on the back of its portfolio of consumer brands and focus on core strategies to achieve long-term success. zacks.com 2025-03-27 12:10:27 Czytaj oryginał (ang.)
Should You Consider Retaining PBH Stock in Your Portfolio Now? Investors remain optimistic about Prestige Consumer due to its strong focus on brand building and strategic acquisition. zacks.com 2025-03-25 11:15:39 Czytaj oryginał (ang.)
Premium Brands Holdings Corporation Announces $150 Million Financing of Convertible Unsecured Subordinated Debentures NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 05, 2025 (GLOBE NEWSWIRE) -- Premium Brands Holdings Corporation (“Premium Brands” or the “Company”) (TSX: PBH), a leading producer, marketer and distributor of branded specialty food products, is pleased to announce it has entered into an agreement with a syndicate of underwriters co-led by CIBC Capital Markets, National Bank Financial, BMO Capital Markets and Scotiabank (collectively, the “Underwriters”), pursuant to which the Company will issue on a “bought-deal” basis, subject to regulatory approval, $150,000,000 aggregate principal amount of convertible unsecured subordinated debentures (the “Debentures”) at a price of $1,000 per Debenture (the “Offering”). The Company has also granted the Underwriters an over-allotment option to purchase up to an additional $22,500,000 aggregate principal amount of Debentures, on the same terms, exercisable in whole or in part at any time for a period of up to 30 days following closing of the Offering, to cover over-allotments, if any. globenewswire.com 2025-03-05 18:16:00 Czytaj oryginał (ang.)
PBH or BSX: Which Is the Better Value Stock Right Now? Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com 2025-02-17 14:46:17 Czytaj oryginał (ang.)
PBH Q3 Earnings Beat Estimates, EPS View Raised, Shares Gain 14.8% Prestige Consumer Healthcare witnesses continued international growth in the third quarter, banking on strong sales of the Hydralyte brand. zacks.com 2025-02-07 12:25:58 Czytaj oryginał (ang.)
Prestige Consumer Healthcare Inc. (PBH) Q3 2025 Earnings Call Transcript Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q3 2025 Results Conference Call February 6, 2025 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chairman, President & Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer & Company Susan Anderson - Canaccord Genuity Keith Devas - Jefferies David Shakno - William Blair Linda Bolton Weiser - D. A. Davidson Anthony Lebiedzinski - Sidoti & Company Operator Thank you for standing by, and welcome to Prestige Consumer Healthcare's Third Quarter 2025 Earnings Conference Call. seekingalpha.com 2025-02-06 13:02:02 Czytaj oryginał (ang.)
Prestige Consumer Healthcare (PBH) Q3 Earnings and Revenues Beat Estimates Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.06 per share a year ago. zacks.com 2025-02-06 10:11:09 Czytaj oryginał (ang.)
Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook TARRYTOWN, N.Y., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2024. globenewswire.com 2025-02-06 08:00:00 Czytaj oryginał (ang.)
PBH vs. BSX: Which Stock Is the Better Value Option? Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now? zacks.com 2025-01-31 14:41:19 Czytaj oryginał (ang.)
Prestige Consumer Stock Up 29.9% in a Year: What's Behind the Surge? PBH sees remarkable gains from long-term brand-building strategies and developing the e-commerce channel. zacks.com 2025-01-22 11:25:26 Czytaj oryginał (ang.)
PBH or BSX: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2025-01-15 14:41:15 Czytaj oryginał (ang.)
PBH vs. BSX: Which Stock Is the Better Value Option? Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now? zacks.com 2024-12-30 14:41:20 Czytaj oryginał (ang.)
5 Beaten-Down MedTech Stocks Set to Rebound in 2025 Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape. zacks.com 2024-12-30 11:25:28 Czytaj oryginał (ang.)
Should Prestige Consumer Stock Stay in Your Portfolio Right Now? Investors remain optimistic about PBH stock due to its strong focus on brand building. zacks.com 2024-12-26 10:01:15 Czytaj oryginał (ang.)
PBH or ABT: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now? zacks.com 2024-12-13 14:42:25 Czytaj oryginał (ang.)
Premium Brands Holdings: Serving Up Protein On Both Sides Of The Border Premium Brands Holdings has expanded from Western Canada to the US, focusing on specialty foods and wholesale distribution through acquisitions. PBH aims for $10B annual revenue by 2027, leveraging a portfolio mix of proteins, baked goods, and distribution, with 70% sales from foodservice and retail chains. The macro environment suggests lower interest rates, but inflation and wage increases could impact PBH's middle and low-income customer base. seekingalpha.com 2024-12-06 13:24:35 Czytaj oryginał (ang.)
PBH or SYK: Which Is the Better Value Stock Right Now? Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors? zacks.com 2024-11-27 14:46:30 Czytaj oryginał (ang.)
PBH vs. SYK: Which Stock Is the Better Value Option? Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors? zacks.com 2024-11-11 14:45:35 Czytaj oryginał (ang.)
Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Transcript Prestige Consumer Healthcare Inc (NYSE:PBH ) Q2 2025 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chairman, President & Chief Executive Officer Chris Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer Susan Anderson - Canaccord Anthony Lebiedzinski - Sidoti & Co. Operator Good day, ladies and gentlemen, and welcome to Prestige Consumer Healthcare's Second Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. seekingalpha.com 2024-11-09 13:50:23 Czytaj oryginał (ang.)
PBH Q2 Earnings Match Estimates, Revenues Beat, Shares Rise Prestige Consumer Healthcare's second-quarter sales are impacted by the ongoing supply chain challenges in the Clear Eyes business. zacks.com 2024-11-08 13:02:21 Czytaj oryginał (ang.)
Prestige Consumer Healthcare (PBH) Meets Q2 Earnings Estimates Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.09 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.07 per share a year ago. zacks.com 2024-11-07 10:15:20 Czytaj oryginał (ang.)
PBH or SYK: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com 2024-10-23 16:45:31 Czytaj oryginał (ang.)
PBH vs. SYK: Which Stock Is the Better Value Option? Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-10-07 16:46:16 Czytaj oryginał (ang.)
PBH or SYK: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now? zacks.com 2024-09-20 16:41:16 Czytaj oryginał (ang.)
What Makes Prestige Consumer Healthcare (PBH) a Good Fit for 'Trend Investing' Prestige Consumer Healthcare (PBH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen. zacks.com 2024-09-20 13:56:15 Czytaj oryginał (ang.)
PBH or SYK: Which Is the Better Value Stock Right Now? Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-09-04 16:41:06 Czytaj oryginał (ang.)
Here's Why 'Trend' Investors Would Love Betting on Prestige Consumer Healthcare (PBH) Prestige Consumer Healthcare (PBH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen. zacks.com 2024-09-04 13:51:12 Czytaj oryginał (ang.)
Prestige Consumer Healthcare Inc. (PBH) Q2 2024 Earnings Call Transcript Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Phil Terpolilli - Director of IR Ron Lombardi - Chairman, President & CEO Chris Sacco - CFO Conference Call Participants Rupesh Parikh - Oppenheimer Susan Anderson - Canaccord Linda Bolton-Weiser - D.A. Davidson Anthony Lebiedzinski - Sidoti & Co. Mitchell Pinheiro - Sturdivant Trevor Sahr - William Blair Operator Welcome to the Q1 2025 Prestige Consumer Healthcare Inc. Earnings Conference Call. seekingalpha.com 2024-08-08 15:20:30 Czytaj oryginał (ang.)
Prestige Consumer Healthcare (PBH) Reports Q1 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Prestige Consumer Healthcare (PBH) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2024-08-08 14:35:44 Czytaj oryginał (ang.)
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results TARRYTOWN, N.Y., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2024. globenewswire.com 2024-08-08 10:00:00 Czytaj oryginał (ang.)
AHCO or PBH: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Products sector have probably already heard of AdaptHealth Corp. (AHCO) and Prestige Consumer Healthcare (PBH). But which of these two stocks is more attractive to value investors? zacks.com 2024-07-09 16:45:44 Czytaj oryginał (ang.)